In suspected necrotizing fasciitis, which antibiotic combination provides broad-spectrum coverage appropriate for initial empiric therapy?

In suspected necrotizing fasciitis, which antibiotic combination provides broad-spectrum coverage appropriate for initial empiric therapy?

• A. Cefazolin + metronidazole
• B. Penicillin G
• C. Doxycycline
• D. IV vancomycin + meropenem

Answer: (D)

Necrotizing fasciitis requires immediate broad-spectrum IV antibiotics that cover MRSA, a wide range of Gram-negative bacteria, and anaerobes because the infection is often polymicrobial and progresses rapidly. IV vancomycin provides reliable MRSA coverage, while meropenem is a broad-spectrum carbapenem that covers most Gram-negatives (including Pseudomonas) and anaerobes. Together, they cover the key pathogens you’d worry about at presentation while cultures are pending. Other regimens lack either MRSA coverage or broad Gram-negative/anaerobic activity, making them less suitable for initial empiric therapy in this setting.

Necrotizing fasciitis requires immediate broad-spectrum IV antibiotics that cover MRSA, a wide range of Gram-negative bacteria, and anaerobes because the infection is often polymicrobial and progresses rapidly. IV vancomycin provides reliable MRSA coverage, while meropenem is a broad-spectrum carbapenem that covers most Gram-negatives (including Pseudomonas) and anaerobes. Together, they cover the key pathogens you’d worry about at presentation while cultures are pending. Other regimens lack either MRSA coverage or broad Gram-negative/anaerobic activity, making them less suitable for initial empiric therapy in this setting.